COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.

Chen, Yu-Wei; Tucker, Matthew D; Beckermann, Kathryn E; Iams, Wade T; Rini, Brian I; Johnson, Douglas B

Chen, Yu-Wei; Tucker, Matthew D; Beckermann, Kathryn E; Iams, Wade T; Rini, Brian I; Johnson, Douglas B.

Chen YW; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Tucker MD; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Beckermann KE; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Iams WT; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Rini BI; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.
Johnson DB; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: douglas.b.johnson@vumc.org.

Eur J Cancer ; 155: 291-293, 2021 09.

Article in English | MEDLINE | ID: covidwho-1330795

Subject(s)

COVID-19 Vaccines/administration & dosage; COVID-19 Vaccines/adverse effects; Immune Checkpoint Inhibitors/administration & dosage; Immune Checkpoint Inhibitors/adverse effects; Aged; COVID-19 Vaccines/immunology; Female; Humans; Immune Checkpoint Inhibitors/immunology; Male; Middle Aged; Neoplasms/drug therapy; Neoplasms/immunology; Vaccines, Synthetic/administration & dosage; Vaccines, Synthetic/adverse effects; Vaccines, Synthetic/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immune Checkpoint Inhibitors / COVID-19 Vaccines Topics: Vaccines Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Eur J Cancer Year: 2021 Document Type: Article Affiliation country: J.ejca.2021.07.017

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google